# ParaGen Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/paragen-technologies

- Industry: Medical Devices & Equipment
- Headquarters: Columbus, US
- Website: www.paragentechnologies.com
- Total disclosed funding: $4.1M
- Latest round: Seed (Dec 8, 2017)
- Investors on record: 1

## About

ParaGen Technologies specializes in innovative tissue engineering solutions, focusing on synthetic nanofiber scaffolds that support tissue regeneration and healing in medical applications.Founded in 2016 and headquartered in Columbus, US, ParaGen Technologies develops advanced tissue engineering products. The company has engaged in 4 deals to date, with its most recent funding round occurring on June 11, 2019, where it raised USD 0.35 mn. The leadership team includes CEO Ronald Bracken and Ross Kayuha, while Flavio Lobato serves as the founder.ParaGen Technologies specializes in advanced tissue engineering solutions, primarily through the development of synthetic nanofiber scaffolds that mimic the extracellular matrix found in the human body. These scaffolds are designed to promote healing and tissue regeneration across various medical verticals, including wound care, orthopedics, vascular applications, and hernia repair. By addressing common issues associated with both synthetic and biologic implants, such as cell integration rejection and degradation, the company aims to offer a more effective environment for cellular adhesion and proliferation. ParaGen Technologies' products are utilized in clinical settings within North America and Europe, catering to healthcare providers, hospitals, and specialized medical device companies seeking innovative solutions for complex tissue repair challenges.The revenue model of ParaGen Technologies is structured around direct B2B transactions with healthcare providers and medical device companies, facilitated through partnerships and collaborations. The company leverages its proprietary technology and its portfolio of products, including flagship offerings like RenovoDerm and Atreon Orthopedics, to generate sales within the medical device market. Transactions typically involve bulk orders or contractual agreements for specific clinical solutions, ensuring that clients receive tailored products to meet their needs. While specific pricing details for the products and services are not disclosed, the revenue is derived from the sale of these innovative medical solutions designed to enhance patient outcomes and streamline the healing process.ParaGen Technologies aims to leverage its recent funding of USD 0.35 mn, raised in June 2019, for the development of new products and expansion into new markets. The company plans to introduce additional tissue engineering solutions focusing on key medical verticals. Furthermore, it is exploring opportunities to enter new geographic regions, targeting expansion efforts within Asia and South America by 2023.

## Funding rounds

- Seed, Dec 8, 2017, $4.1M — Ikove Startup Nursery

## Investors

- Ikove Startup Nursery (https://capitalatlas.ai/funds/ikove-startup-nursery) — Seed